Valneva SE

AYJ

Company Profile

  • Business description

    Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.

  • Contact

    6 Rue Alain Bombard
    Saint-Herblain44800
    FRA

    T: +33 228073710

    E: [email protected]

    https://www.valneva.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    676

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,158.709.800.12%
CAC 408,042.9551.25-0.63%
DAX 4022,891.68107.47-0.47%
Dow JONES (US)41,985.3532.030.08%
FTSE 1008,646.7955.20-0.63%
HKSE23,689.72530.23-2.19%
NASDAQ17,784.0592.420.52%
Nikkei 22537,677.0674.82-0.20%
NZX 50 Index12,113.5458.820.49%
S&P 5005,667.564.670.08%
S&P/ASX 2007,931.2012.300.16%
SSE Composite Index3,364.8344.12-1.29%

Market Movers